All Archives - Page 11 of 11

All Features

Research Study Opportunity

There is an opportunity to participate in a research study interview taking place for those with knowledge of the biopharmaceutical industry in Switzerland. The research should…

clement11.05.2020

All Features

Looking for people for exciting projects

We are supporting an exciting project that exploits the role and vulnerabilities of circulating tumor cell clusters, major mediators of metastasis. The team is developing…

clement11.05.2020

All Features

KPMG: COVID-19 feature- Build resilience

From our partner, KPMG: Proving an online knowledge base for the COVID-19 times. KPMG has put together an online resource page for these challenging and…

clement08.05.2020

All Portfolio news

Anaveon raises CHF 35 million

Anaveon, a Basel-based immuno-oncology biotech, has successfully concluded a Series A financing round led by Syncona, a UK Life Sciences fund, and joined by the…

clement05.03.2020

All Portfolio news

Polyneuron raises CHF 22.5 million in Series A financing

Polyneuron Pharmaceuticals, one of our portfolio companies has successfully raised 22.5 million francs in a round of financing. The Basel-based company will use the proceeds…

clement04.03.2020

All Portfolio news

Alentis raises 12.5 million Swiss francs

The Basel-based biotech company Alentis Therapeutics AG has successfully concluded a CHF 12.5 million Series A financing co-lead by BioMedPartners and BB Pureos Bioventures and joined by…

clement03.03.2020

All Portfolio news

T3 Pharma raises over $12 million

T3 Pharma, a spin-off of the University of Basel and one of our portfolio, has raised over $12 million from Boehringer Ingelheim Venture Fund and…

clement02.03.2020

All Portfolio news

Versameb raises 6.4 million Swiss francs

Basel-based biopharmaceutical Versameb has raised 6.4 million Swiss francs in a Seed C financing round and will put the funds towards expanding its technology platform.…

clement01.03.2020

All

Research Study Opportunity

Looking for people for exciting projects

KPMG: COVID-19 feature- Build resilience

Anaveon raises CHF 35 million

Polyneuron raises CHF 22.5 million in Series A financing

Alentis raises 12.5 million Swiss francs

T3 Pharma raises over $12 million

Versameb raises 6.4 million Swiss francs

Useful links

Contact us

Sign up for our newsletter and event invitations

Follow us